VEGFA and neoplasm: Exosomal MiR-126 derived from HUVECs was found to interact with MNSC cells, leading to increased MiR-126 levels, whereby inducing anti-tumour responses such as inhibition of cell proliferation and target gene modulation including IRS1 and VEGF (cf Fig. 4).